Homepage
Author:
Panome Bio
Posted Date:
April 16, 2026
Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
Panome Bio
April 16, 2026
Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease
Panome Bio
March 5, 2026
Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development
Panome Bio
February 25, 2026
